Fundación io

Summary

Every second a new person is exposed to tuberculosis (TB). Each untreated TB-infected person will infect 10-15 people every year. Following the success of its predecessor, this new edition of Tuberculosis scrutinizes the new discoveries and observations of the key aspects of the disease while delivering the information in a very manageable 416-page format. Recognized world TB experts:

• Provide a concise, state-of-the-art review of the 15 essential elements of TB
• Supply an international, current view of the epidemiology, pathophysiology, diagnosis, and treatment methods
• Discuss the emerging threat of XDR-TB and the HIV/AIDS factor
• Assess advances in TB research such as new drugs and vaccines
• Reflect on the progress of the “Stop TB” strategy

Table of Contents

The Global TB Epidemic, Christopher Dye, Glaziou Philippe, and Hosseini Syed
Epidemiology of TB, Megan Murray
Pathogenesis of TB, Samuel Woolwine and William Bishai
Diagnosis of Pulmonary & Extrapulmonary TB, Phung Lam, Sharon Perry, and Antonio Catanzaro
Treatment of TB, Philip Hopewell
TB-HIV Co-Infection, Haileyesus Getahun, Alasdair Reid, and Enrico Girardi
Diagnosis and Treatment of Multidrug-Resistant TB, Michael Rich and Kwonjune Seung
Achieving Higher Case Detection, Knut Lonnroth, Mukund Uplekar, and Leopold Blanc
Anti-TB Drug Resistance in the World, Abigail Wright and Matteo Zignol
Programmatic Control of Multidrug-Resistant TB, Michael Kimerling, Ernesto Jaramillo, and Kitty Lambregts
Programmatic Management of HIV-Associated TB, Anthony Harries and Paul Nunn
The Stop TB Strategy, Mukund Uplekar, Diana Weil, and Mario Raviglione
New Diagnostics for TB, Mark Perkins and Richard O’Brien
New Drugs for TB, Ann Ginsberg and Melvin Spigelman
New Vaccines for TB, Douglas Young and Jelle Thole

Autor

Raviglione, Mario